• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有尿路感染并出现血尿,随后发生多次出血且因子V抑制剂水平极低的患者获得性因子V缺乏症:病例报告及文献复习

Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.

作者信息

Wang Xiangyu, Qin Xuemei, Yu Yuan, Wang Ran, Liu Xinguang, Ji Min, Zhou Minran, Chen Chunyan

机构信息

Department of Hematology, Qilu Hospital, Shandong University, Jinan, Shandong, P. R. China.

出版信息

Blood Coagul Fibrinolysis. 2017 Jun;28(4):334-341. doi: 10.1097/MBC.0000000000000581.

DOI:10.1097/MBC.0000000000000581
PMID:27428013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5432097/
Abstract

: Acquired factor V deficiency (AFVD) is a rare haemostatic disorder that is primarily because of the development of factor V inhibitors. Approximately, 200 cases have been reported and the greatest portion of these cases was because of bovine thrombin exposure. We report a case of a man who presented with haematuria followed by multiple haemorrhages associated with an elevated prothrombin time and an activated partial thromboplastin time. A workup revealed reduced factor V activity and a factor V inhibitor level of 1.9 BU, which were likely secondary to a urinary tract infection. Using corticosteroids, we successfully eliminated the inhibitor and controlled the bleeding. We review the published literature to identify the conditions that are associated with nonbovine thrombin AFVD. We assume that AFVD should be kept in mind for patients who present with multiple haemorrhages.

摘要

获得性因子V缺乏症(AFVD)是一种罕见的止血障碍,主要是由于因子V抑制剂的产生。大约已报告了200例病例,其中大部分病例是由于接触牛凝血酶所致。我们报告一例男性患者,该患者先出现血尿,随后出现多处出血,同时凝血酶原时间和活化部分凝血活酶时间升高。检查发现因子V活性降低,因子V抑制剂水平为1.9 BU,这可能继发于尿路感染。使用皮质类固醇,我们成功消除了抑制剂并控制了出血。我们回顾已发表的文献以确定与非牛凝血酶AFVD相关的情况。我们认为,对于出现多处出血的患者应考虑到AFVD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/7c09b3e7bd2f/blcof-28-334-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/54271534444f/blcof-28-334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/7be7d29a5f1f/blcof-28-334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/7c09b3e7bd2f/blcof-28-334-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/54271534444f/blcof-28-334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/7be7d29a5f1f/blcof-28-334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0f/5432097/7c09b3e7bd2f/blcof-28-334-g003.jpg

相似文献

1
Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.一名患有尿路感染并出现血尿,随后发生多次出血且因子V抑制剂水平极低的患者获得性因子V缺乏症:病例报告及文献复习
Blood Coagul Fibrinolysis. 2017 Jun;28(4):334-341. doi: 10.1097/MBC.0000000000000581.
2
Acquired Factor V Deficiency Associated with CFPM Administration.与CFPM给药相关的获得性因子V缺乏症。
Clin Lab. 2019 Oct 1;65(10). doi: 10.7754/Clin.Lab.2019.190240.
3
Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review.血浆置换治疗获得性因子 V 缺乏症致严重出血 1 例报告并文献复习
Acta Haematol. 2021;144(1):82-87. doi: 10.1159/000505770. Epub 2020 Aug 12.
4
Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.小儿患者局部应用牛凝血酶后出现抗人凝血酶和抗凝血因子 V 抗体
Pediatr Blood Cancer. 2010 Dec 1;55(6):1195-7. doi: 10.1002/pbc.22699.
5
Transfusion management of factor V deficiency: three case reports and review of the literature.因子V缺乏症的输血管理:三例病例报告及文献综述
Transfusion. 2016 Jul;56(7):1745-9. doi: 10.1111/trf.13623. Epub 2016 Apr 28.
6
Development of cephradine-induced acquired factor V inhibitors: a case report.头孢拉定诱导获得性因子 V 抑制剂的发展:一例报告。
Ann Pharmacother. 2010 Oct;44(10):1673-6. doi: 10.1345/aph.1P324. Epub 2010 Aug 31.
7
High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.两名获得性因子V抑制剂患者的大剂量静脉注射免疫球蛋白治疗
Am J Hematol. 2003 Nov;74(3):187-90. doi: 10.1002/ajh.10420.
8
Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.接触局部人凝血酶后获得性因子 V 抑制剂与耳鼻喉科手术相关。
J Thromb Haemost. 2015 Oct;13(10):1787-9. doi: 10.1111/jth.13114. Epub 2015 Sep 30.
9
Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.一名食管鳞状细胞癌患者发生获得性凝血因子V抑制剂。
Blood Coagul Fibrinolysis. 2013 Jan;24(1):97-9. doi: 10.1097/MBC.0b013e328359bc59.
10
Thrombin generation in a patient with an acquired high-titre factor V inhibitor.
Blood Coagul Fibrinolysis. 2015 Jan;26(1):81-7. doi: 10.1097/MBC.0000000000000181.

引用本文的文献

1
A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis.严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗接种后发生自身免疫性获得性因子V缺乏症的首例病例报告——在开始血液透析时。
Nephrology (Carlton). 2025 Feb;30(2):e70003. doi: 10.1111/nep.70003.
2
A single-center study of patients with rare isolated acquired clotting factor deficiencies other than acquired hemophilia A.一项针对除获得性血友病A之外的罕见孤立性获得性凝血因子缺乏症患者的单中心研究。
Res Pract Thromb Haemost. 2024 Aug 23;8(6):102554. doi: 10.1016/j.rpth.2024.102554. eCollection 2024 Aug.
3

本文引用的文献

1
Transfusion management of factor V deficiency: three case reports and review of the literature.因子V缺乏症的输血管理:三例病例报告及文献综述
Transfusion. 2016 Jul;56(7):1745-9. doi: 10.1111/trf.13623. Epub 2016 Apr 28.
2
Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia.与V因子抑制剂相关的深静脉血栓形成,随后出现免疫性血小板减少症。
Ann Hematol. 2012 Nov;91(11):1831-2. doi: 10.1007/s00277-012-1485-3. Epub 2012 May 16.
3
Acquired factor V inhibitors: a systematic review.获得性因子 V 抑制剂:系统评价。
Rare Coagulopathies in Hematologic Spotlight: Isolated Factor V Deficiency and Combined Factor V and VIII Deficiency.
血液学聚焦中的罕见凝血障碍:孤立性因子V缺乏症及因子V和VIII联合缺乏症
Int J Appl Basic Med Res. 2024 Apr-Jun;14(2):142-146. doi: 10.4103/ijabmr.ijabmr_67_24. Epub 2024 May 24.
4
Use of Thromboelastography in Coronary Artery Bypass Grafting in a Patient With Factor Ⅴ Deficiency With Platelet Function Disorders: A Case Report and Literature Review.血栓弹力图在一名伴有血小板功能障碍的Ⅴ因子缺乏患者冠状动脉旁路移植术中的应用:病例报告及文献复习
Cureus. 2024 Apr 13;16(4):e58185. doi: 10.7759/cureus.58185. eCollection 2024 Apr.
5
[Pathophysiology, diagnosis, and therapy for the management of acquired clotting factor deficiency].[获得性凝血因子缺乏症的病理生理学、诊断及治疗管理]
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):956-962. doi: 10.3760/cma.j.issn.0253-2727.2023.11.014.
6
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement.获得性因子 V 抑制剂伴妊娠相关改善,经免疫抑制治疗无效后延迟自发性缓解。
Pathol Oncol Res. 2023 Jun 2;29:1611250. doi: 10.3389/pore.2023.1611250. eCollection 2023.
7
Spontaneous Retroperitoneal Hematoma in Vitamin C Deficiency.维生素C缺乏所致自发性腹膜后血肿
J Community Hosp Intern Med Perspect. 2023 Mar 10;13(2):41-45. doi: 10.55729/2000-9666.1161. eCollection 2023.
8
A case of unusual acquired factor V deficiency.一例罕见的获得性凝血因子V缺乏症病例。
World J Emerg Med. 2023;14(1):78-80. doi: 10.5847/wjem.j.1920-8642.2023.003.
9
Owren's Disease: A Rare Deficiency.奥伦氏病:一种罕见的缺陷。
Cureus. 2021 Aug 10;13(8):e17047. doi: 10.7759/cureus.17047. eCollection 2021 Aug.
10
Development of Acquired Factor V Inhibitor After Surgical Procedure Without the Use of Fibrin Tissue Adhesives: A Case Report.未使用纤维蛋白组织粘合剂的手术后获得性因子V抑制剂的发生:一例报告
Cureus. 2021 Jan 14;13(1):e12708. doi: 10.7759/cureus.12708.
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.
4
Development of cephradine-induced acquired factor V inhibitors: a case report.头孢拉定诱导获得性因子 V 抑制剂的发展:一例报告。
Ann Pharmacother. 2010 Oct;44(10):1673-6. doi: 10.1345/aph.1P324. Epub 2010 Aug 31.
5
Acquired factor V inhibitor. A problem-based systematic review.获得性凝血因子V抑制剂。基于问题的系统评价。
Thromb Haemost. 2009 May;101(5):852-9.
6
Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.重组活化凝血因子 VII 在治疗继发于凝血因子 V 抑制剂的出血中的辅助作用。
Blood Coagul Fibrinolysis. 2008 Jun;19(4):327-8. doi: 10.1097/MBC.0b013e3283001d49.
7
Coagulation factor V and thrombophilia: background and mechanisms.凝血因子V与血栓形成倾向:背景与机制
Thromb Haemost. 2007 Sep;98(3):530-42.
8
Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation.
Blood Coagul Fibrinolysis. 2004 Oct;15(8):637-47. doi: 10.1097/00001721-200412000-00003.
9
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations.
Blood. 2002 Jun 1;99(11):3985-92. doi: 10.1182/blood.v99.11.3985.
10
Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features.
Am J Hematol. 1998 Feb;57(2):176-8. doi: 10.1002/(sici)1096-8652(199802)57:2<176::aid-ajh14>3.0.co;2-a.